Galmed Pharmaceuticals | EFFECT: Others
Galmed Pharmaceuticals | 424B3: Prospectus
Galmed Pharmaceuticals | F-1: Registration statement for securities of certain foreign private issuers
Galmed Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Galmed Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Galmed Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Galmed Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Galmed Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-MASAYA OTSUKA(0%)
Galmed Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-MASAYA OTSUKA(9.9%)
Galmed Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Galmed Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Galmed Pharmaceuticals | EFFECT: Others
Galmed Pharmaceuticals | CORRESP: CORRESP
Galmed Pharmaceuticals | UPLOAD: Others
Galmed Pharmaceuticals | 424B3: Prospectus
Galmed Pharmaceuticals | F-1: Registration statement for securities of certain foreign private issuers
Galmed Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)
Galmed Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)
Galmed Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Galmed Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
No Data
No Data